Findings

What do systematic reviews say?

43 questions · 43 findings · 7 reviews · Airways

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 1 · 2.3%Very low 2 · 4.7%Low 10 · 23.3%Moderate 26 · 60.5%High 4 · 9.3%

Formoterol vs short‐acting beta2‐agonist

Patients with a serious adverse event (all cause) · people with asthma

Formoterol showed no clear difference in patients with a serious adverse event (all cause) compared with short‐acting beta2‐agonist (low certainty).

1 finding from 1 review

Formoterol versus short‐acting beta‐agonists as relief medication for adults and children with asthma 2010 · Cochrane Headline outcomes only
OR 0.94 [0.81, 1.08]
7 studies · 22538 participants
Low

Formoterol vs short‐acting beta2‐agonist

Asthma‐related serious adverse event · people with asthma

Formoterol showed no clear difference in patients with a serious adverse event (asthma related) compared with short‐acting beta2‐agonist (low certainty).

1 finding from 1 review

Formoterol versus short‐acting beta‐agonists as relief medication for adults and children with asthma 2010 · Cochrane Headline outcomes only
OR 0.91 [0.72, 1.15]
6 studies · 21986 participants
Low

Formoterol vs short‐acting beta2‐agonist

Withdrawals due to any reason · people with asthma

Formoterol may leads to higher withdrawals (any reason) compared with short‐acting beta2‐agonist (low certainty).

1 finding from 1 review

Formoterol versus short‐acting beta‐agonists as relief medication for adults and children with asthma 2010 · Cochrane Headline outcomes only
OR 1.12 [1.02, 1.24]
7 studies · 22541 participants
Low